The progress of peptide vaccine clinical trials in gynecologic oncology.
Quick Facts
What This Study Found
No peptide vaccine has been licensed for gynecologic oncology as of January 2022.
Key Numbers
How They Did This
The study is a review of clinical trials registered on ClinicalTrials.gov up to January 1, 2022.
Why This Research Matters
Understanding the progress of peptide vaccines can lead to improved treatments for gynecologic cancers. This research highlights the need for continued innovation in immunotherapy.
What This Study Doesn't Tell Us
The review does not provide new clinical trial data or outcomes, focusing instead on existing studies.
Trust & Context
- Original Title:
- The progress of peptide vaccine clinical trials in gynecologic oncology.
- Published In:
- Human vaccines & immunotherapeutics, 18(5), 2062982 (2022)
- Authors:
- Tang, Mi, Cai, Jiang-Hui, Diao, Hao-Yang, Guo, Wen-Mei, Yang, Xiao, Xing, ShaSha
- Database ID:
- RPEP-06534
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06534APA
Tang, Mi; Cai, Jiang-Hui; Diao, Hao-Yang; Guo, Wen-Mei; Yang, Xiao; Xing, ShaSha. (2022). The progress of peptide vaccine clinical trials in gynecologic oncology.. Human vaccines & immunotherapeutics, 18(5), 2062982. https://doi.org/10.1080/21645515.2022.2062982
MLA
Tang, Mi, et al. "The progress of peptide vaccine clinical trials in gynecologic oncology.." Human vaccines & immunotherapeutics, 2022. https://doi.org/10.1080/21645515.2022.2062982
RethinkPeptides
RethinkPeptides Research Database. "The progress of peptide vaccine clinical trials in gynecolog..." RPEP-06534. Retrieved from https://rethinkpeptides.com/research/tang-2022-the-progress-of-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.